S-EPMC12304727 - Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment. - OmicsDI

Unknown

Dataset Information

Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment.

ABSTRACT:

SUBMITTER: Li N

PROVIDER: S-EPMC12304727 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature